INTERSTITIAL LUNG DISEASE: RETROSPECTIVE STUDY OF THE PROGNOSTIC IMPACT OF ACUTE EXACERBATIONS

被引:0
|
作者
Pacheco, Joana M. [1 ]
Santos, Ana I. [1 ]
Catarata, Joana [2 ]
Freitas, Sara [1 ]
机构
[1] Coimbra Hosp & Univ Ctr, Pulmonol Dept, Mota Pinto,3004-56, Coimbra, Portugal
[2] Braga Hosp, Pulmonol Dept, Braga, Portugal
关键词
KEY WORDS: interstitial lung disease; pulmonary fibrosis; acute exacerbation;
D O I
10.36141/svdld.v41i4.15198
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Interstitial lung diseases have high mortality associated with hospitalization for decompensation. There are doubts about the factors involved in the progression of fibrosis, for example the role played by acute exacerbations. With this work, the authors intend to analyze whether there are predictive parameters of mortality related to exacerbations. Methods: A retrospective study was carried out of patients admitted to the Pulmonology department of Coimbra University Hospital Center for exacerbation of fibrosing lung disease between January 2019 and December 2020. These were classified as: idiopathic pulmonary fibrosis (IPF), fibrosing hypersensivity pneumonitis (FHP) and other fibrosing lung diseases. Statistical analysis was performed using SPSS 26.0 considering statistically significant p<0.05 values. Results: The results show that IPF is associated with longer hospital stay in relation to fibrosing HP and other fibrosing lung diseases mean of 20.93 days (95% CI: 14.69-27.18) vs 11.8 days (95% CI: 1.05-17.22, p=0.023) vs 12.23 days (95% CI: 2.06-15.34, p=0.007), respectively. Regarding mortality, there was no difference between IPF, PH and other fibrosing diseases (p=0.631). Conclusion: This study demonstrated that IPF, compared to PH and other fibrosing diseases, is associated with longer hospital stays, probably due to its progressive course despite the institution of corticosteroid therapy. As shown in previous studies, it was concluded that there is no difference in terms of mortality between IPF exacerbations and other forms of fibrosing lung disease.
引用
收藏
页数:4
相关论文
共 50 条
  • [31] INCIDENCE OF ACUTE EXACERBATIONS AMONG PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASE IN THE UNITED STATES
    Yang, J.
    Ide, J.
    Olson, A.
    VALUE IN HEALTH, 2024, 27 (06) : S44 - S44
  • [32] Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
    Cao, Mengshu
    Sheng, Jian
    Qiu, Xiaohua
    Wang, Dandan
    Wang, Dongmei
    Wang, Yang
    Xiao, Yonglong
    Cai, Hourong
    BMC PULMONARY MEDICINE, 2019, 19 (01)
  • [33] Acute exacerbations of fibrosing interstitial lung disease associated with connective tissue diseases: a population-based study
    Mengshu Cao
    Jian Sheng
    Xiaohua Qiu
    Dandan Wang
    Dongmei Wang
    Yang Wang
    Yonglong Xiao
    Hourong Cai
    BMC Pulmonary Medicine, 19
  • [34] Acute exacerbations of interstitial lung disease: Don't just do something, stand there!
    Lentz, Robert J.
    Maldonado, Fabien
    RESPIROLOGY, 2017, 22 (02) : 215 - 216
  • [35] Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung disease
    Furuta, Katsuyuki
    Fujimoto, Daichi
    Matsunashi, Atsushi
    Shibaki, Ryota
    Taniya, Shinnosuke
    Tanaka, Masanori
    Shimada, Yuri
    Nagata, Kazuma
    Tomii, Keisuke
    Yamamoto, Nobuyuki
    RESPIRATORY MEDICINE, 2024, 231
  • [36] Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study
    Ji Su-yun
    Zeng Fan-qin
    Guo Qing
    Tan Guo-zhen
    Tang Hong-feng
    Luo Yi-jin
    Tang Zeng-qi
    Han Yan-fang
    CHINESE MEDICAL JOURNAL, 2010, 123 (05) : 517 - 522
  • [37] Monocyte count and the risk for acute exacerbation of fibrosing interstitial lung disease: A retrospective cohort study
    Kawamura, Kodai
    Ichikado, Kazuya
    Anan, Keisuke
    Yasuda, Yuko
    Sekido, Yuko
    Suga, Moritaka
    Ichiyasu, Hidenori
    Sakagami, Takuro
    CHRONIC RESPIRATORY DISEASE, 2020, 17
  • [38] Prognostic impact of HNF4α expression in interstitial lung disease
    Sawazumi, Tomoe
    Baba, Tomohisa
    Iwasawa, Tae
    Arai, Hiromasa
    Matsumura, Mai
    Takemura, Tamiko
    Sugiyama, Misaki
    Sekiya, Motoki
    Saigusa, Yusuke
    Ogura, Takashi
    Inayama, Yoshiaki
    Ohashi, Kenichi
    Okudela, Koji
    PATHOLOGY INTERNATIONAL, 2022, 72 (01) : 25 - 34
  • [39] Frequency and Prognostic Impact of Progressive Fibrosing Phenotype of Interstitial Lung Disease
    Takei, R.
    Yamano, Y.
    Kataoka, K.
    Yokoyama, T.
    Matsuda, T.
    Kimura, T.
    Suzuki, A.
    Kondoh, Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [40] Acute exacerbations of interstitial lung diseases (AE-ILD): impact of an emergency action protocol
    Zapata, Juan Pablo Orozco
    Montero, Ignacio Espanol
    Francesqui, Joel
    Cuerpo, Sandra
    Gonzalez, Fernandez Hernandez
    Benegas, Marina
    Sanchez, Marcelo
    Sellares, Jacobo
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64